mRNA Platform

mRNA Platform
Global mRNA Platform Market to Reach $120.1 Billion by 2030
The global market for mRNA Platform estimated at US$136.2 billion in the year 2022, is projected to decline to US$120.1 Billion by 2030, exhibiting a compounded average rate of decline of -1.6% over the analysis period 2022-2030. Covid-19 Vaccine, one of the segments analyzed in the report, will witness the steepest decline of -4.2% to reach US$96.5 Billion by the end of the analysis period. The decline is led by the waning pandemic, lower disease severity and reduced reliance on vaccines. The Cancer Vaccine segment, on the other hand, will continue to witness robust growth and reach US$18.3 billion over the next 8-year period.

The U.S. Market is Estimated at $61.6 Billion, While China is Forecast to Grow at 0.9% CAGR
The mRNA Platform market in the U.S. is estimated at US$61.6 Billion in the year 2022 and will continue to decline at a rate of -1.8% over the analysis period. China, the world`s second largest economy, is forecast to reach a projected market size of US$13.7 Billion by the year 2030 trailing a CAGR of 0.9% over the analysis period 2022 to 2030. Rest of Asia-Pacific (excluding China) will remain the only other regional market to witness a positive growth of 0.5% over the analysis period to reach a projected market value of US$8.9 billion by 2030. Canada and Japan will each decline at -3.3% and -2.8% respectively over the 2022-2030 period.Select Competitors (Total 96 Featured) - AstraZeneca PLCAsuragen, Inc.Catalent Pharma SolutionsAltogen LabsArcturus Therapeutics, Inc.BioNTech AGCRISPR TherapeuticsAldevronAKESOgen, Inc.baseclick GmbHchimeron bioAcuitas TherapeuticsAccent TherapeuticsAccanis Biotech F&E GmbH & Co KGAvectasPlease note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.